Onderneming Acumen Pharmaceuticals, Inc.
Aandelen
ABOS
US00509G2093
Biotechnologie & Medisch Onderzoek
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
3,4 USD | 0,00% | -6,85% | -11,46% |
Vakgebied
Aantal werknemers: 52
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Daniel O'Connell
CEO | Chief Executive Officer | 54 | 01-04-06 |
Jim Doherty
PSD | President | 56 | 01/02 |
Matthew Zuga
DFI | Director of Finance/CFO | 58 | 01-05-21 |
Kasey Spencer
CTO | Chief Tech/Sci/R&D Officer | - | - |
Russell Barton
COO | Chief Operating Officer | 66 | 01-04-19 |
Eric Siemers
CTO | Chief Tech/Sci/R&D Officer | 68 | 01-06-18 |
Alexandria Braun
IRC | Investor Relations Contact | - | 01-09-22 |
Kathleen Pierce
PRN | Corporate Officer/Principal | - | - |
Amber Dilley
PRN | Corporate Officer/Principal | - | 01-01-21 |
Jasna Jerecic
PRN | Corporate Officer/Principal | - | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Daniel O'Connell
CEO | Chief Executive Officer | 54 | 01-04-06 |
Director/Board Member | 55 | 01-04-22 | |
Jeffrey Ives
BRD | Director/Board Member | 72 | 01-05-14 |
Sean Stalfort
BRD | Director/Board Member | 53 | 01-10-18 |
Derrell Porter
BRD | Director/Board Member | 53 | 04-01-23 |
Laura Stoppel
BRD | Director/Board Member | 38 | 01-11-20 |
Nathan Fountain
BRD | Director/Board Member | 61 | 01-06-21 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 60 079 778 | 53 329 161 ( 88,76 %) | 0 | 88,76 % |
Bedrijfsgegevens
Sector
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-11,46% | 204 mln. | |
+67,53% | 63,85 mld. | |
-0,77% | 41,83 mld. | |
+45,66% | 40,65 mld. | |
-10,72% | 27,12 mld. | |
+13,30% | 26,52 mld. | |
-22,79% | 18,69 mld. | |
+4,70% | 12,73 mld. | |
+24,10% | 12,11 mld. | |
+27,41% | 12,07 mld. |
- Beurs
- Aandelen
- Koers ABOS
- Onderneming Acumen Pharmaceuticals, Inc.